FATE icon

Fate Therapeutics

163 hedge funds and large institutions have $401M invested in Fate Therapeutics in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 59 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership:

less funds holding

Funds holding:

27% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 59

43% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 35

Holders
163
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$239K
Puts
$35K
Net Calls
Net Calls Change

Top Buyers

1 +$7.22M
2 +$3.39M
3 +$1.71M
4
Goldman Sachs
Goldman Sachs
New York
+$1.66M
5
BlackRock
BlackRock
New York
+$1.25M

Top Sellers

1 -$11.4M
2 -$3.96M
3 -$3.39M
4
SCM
Soleus Capital Management
Connecticut
-$2.85M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.45M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$46.1M
2
$36.7M
3
$36.4M
4
$19.5M
5
$18.4M
6
$17.4M
7
$16.9M
8
$15M
9
$12.4M
10
$11.8M
11
$11.8M
12
$10.7M
13
$10.7M
14
$10.5M
15
$9.88M
16
$9.17M
17
$8.52M
18
$7.91M
19
$6.43M
20
$5.9M
21
$5.88M
22
$5.61M
23
$5.56M
24
$5.13M
25
$3.41M